Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $125.5M
Liabilities Breakdown FY2012
Total Liabilities: $29.8M
Asset Breakdown
Total Assets: $125.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $24.9M | 19.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.2M | 5.7% |
| Goodwill | $9.0M | 7.1% |
| Intangible Assets | $23.8M | 19.0% |
| Other Assets | $60.6M | 48.3% |
Liabilities Breakdown
Total Liabilities: $29.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $745.0K | 2.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $29.0M | 97.5% |